103 related articles for article (PubMed ID: 11069465)
1. Efficacy of short-course oral prednisolone in polymorphic light eruption: a randomized controlled trial.
Patel DC; Bellaney GJ; Seed PT; McGregor JM; Hawk JL
Br J Dermatol; 2000 Oct; 143(4):828-31. PubMed ID: 11069465
[TBL] [Abstract][Full Text] [Related]
2. Successful Short Desensitization Treatment Protocol with Narrowband UVB Phototherapy (TL-01) in Polymorphic Light Eruption.
Combalia A; Fernández-Sartorio C; Fustà X; Morgado-Carrasco D; Podlipnik S; Aguilera P
Actas Dermosifiliogr; 2017 Oct; 108(8):752-757. PubMed ID: 28549611
[TBL] [Abstract][Full Text] [Related]
3. Topical liposomal DNA-repair enzymes in polymorphic light eruption.
Hofer A; Legat FJ; Gruber-Wackernagel A; Quehenberger F; Wolf P
Photochem Photobiol Sci; 2011 Jul; 10(7):1118-28. PubMed ID: 21437317
[TBL] [Abstract][Full Text] [Related]
4. A simple method to assess severity of polymorphic light eruption.
Palmer RA; van de Pas CB; Campalani E; Walker SL; Young AR; Hawk JL
Br J Dermatol; 2004 Sep; 151(3):645-52. PubMed ID: 15377352
[TBL] [Abstract][Full Text] [Related]
5. Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care.
Levy ML; Stevenson C; Maslen T
Thorax; 1996 Nov; 51(11):1087-92. PubMed ID: 8958890
[TBL] [Abstract][Full Text] [Related]
6. Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finnish Pulmonary Sarcoidosis Study Group.
Pietinalho A; Tukiainen P; Haahtela T; Persson T; Selroos O
Chest; 1999 Aug; 116(2):424-31. PubMed ID: 10453872
[TBL] [Abstract][Full Text] [Related]
7. Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea.
Sonthalia S; Kumar A; Zawar V; Priya A; Yadav P; Srivastava S; Gupta A
J Dermatolog Treat; 2018 Sep; 29(6):617-622. PubMed ID: 29363373
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic light eruption sine eruption.
Dover JS; Hawk JL
Br J Dermatol; 1988 Jan; 118(1):73-6. PubMed ID: 3342178
[TBL] [Abstract][Full Text] [Related]
9. Prevention of polymorphic light eruption by oral administration of a nutritional supplement containing lycopene, β-carotene, and Lactobacillus johnsonii: results from a randomized, placebo-controlled, double-blinded study.
Marini A; Jaenicke T; Grether-Beck S; Le Floc'h C; Cheniti A; Piccardi N; Krutmann J
Photodermatol Photoimmunol Photomed; 2014 Aug; 30(4):189-94. PubMed ID: 24283388
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Mehndiratta MM
Cochrane Database Syst Rev; 2012 Aug; (8):CD002062. PubMed ID: 22895925
[TBL] [Abstract][Full Text] [Related]
11. Oral steroids for cystic fibrosis.
Cheng K; Ashby D; Smyth R
Cochrane Database Syst Rev; 2000; (2):CD000407. PubMed ID: 10796717
[TBL] [Abstract][Full Text] [Related]
12. Oral prednisolone for preschool children with acute virus-induced wheezing.
Panickar J; Lakhanpaul M; Lambert PC; Kenia P; Stephenson T; Smyth A; Grigg J
N Engl J Med; 2009 Jan; 360(4):329-38. PubMed ID: 19164186
[TBL] [Abstract][Full Text] [Related]
13. Immunopathogenesis and management of polymorphic light eruption.
Kadurina M; Kazandjieva J; Bocheva G
Dermatol Ther; 2021 Nov; 34(6):e15167. PubMed ID: 34676645
[TBL] [Abstract][Full Text] [Related]
14. Erythema multiforme following polymorphic light eruption: a report of two cases.
Fraser-Andrews EA; Morris-Jones R; Novakovic L; Hawk JL
Clin Exp Dermatol; 2005 May; 30(3):232-4. PubMed ID: 15807676
[TBL] [Abstract][Full Text] [Related]
15. A clinicoepidemiological study of polymorphic light eruption.
Sharma L; Basnet A
Indian J Dermatol Venereol Leprol; 2008; 74(1):15-7. PubMed ID: 18187816
[TBL] [Abstract][Full Text] [Related]
16. Polymorphous light eruption (PLE) and a new potent antioxidant and UVA-protective formulation as prophylaxis.
Hadshiew IM; Treder-Conrad C; v Bülow R; Klette E; Mann T; Stäb F; Moll I; Rippke F
Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):200-4. PubMed ID: 15238098
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of efficacy and safety of hydroxychloroquine and chloroquine in polymorphic light eruption: a randomized, double-blind, multicentric study.
Pareek A; Khopkar U; Sacchidanand S; Chandurkar N; Naik GS
Indian J Dermatol Venereol Leprol; 2008; 74(1):18-22. PubMed ID: 18187817
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic PUVA and UVB therapy in polymorphic light eruption--a controlled trial.
Murphy GM; Logan RA; Lovell CR; Morris RW; Hawk JL; Magnus IA
Br J Dermatol; 1987 Apr; 116(4):531-8. PubMed ID: 3555596
[TBL] [Abstract][Full Text] [Related]
19. The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis.
Kirwan JR; Hickey SH; Hällgren R; Mielants H; Björck E; Persson T; Wollheim FA
Arthritis Rheum; 2006 May; 54(5):1415-21. PubMed ID: 16645969
[TBL] [Abstract][Full Text] [Related]
20. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome.
Abeyagunawardena AS; Thalgahagoda RS; Dissanayake PV; Abeyagunawardena S; Illangasekera YA; Karunadasa UI; Trompeter RS
Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
